Luke CJ - Search Results

1

An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults.

Talaat KR, Karron RA, Luke CJ, Thumar B, McMahon BA, Chen GL, Lamirande EW, Jin H, Coelingh KL, Kemble G, Subbarao K. Talaat KR, et al. Among authors: luke cj. Vaccine. 2011 Apr 12;29(17):3144-8. doi: 10.1016/j.vaccine.2011.02.043. Epub 2011 Mar 4. Vaccine. 2011. PMID: 21377509 Free PMC article. Clinical Trial.

2

Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine.

Edelman R, Palmer K, Russ KG, Secrest HP, Becker JA, Bodison SA, Perry JG, Sills AR, Barbour AG, Luke CJ, Hanson MS, Stover CK, Burlein JE, Bansal GP, Connor EM, Koenig S. Edelman R, et al. Among authors: luke cj. Vaccine. 1999 Feb 26;17(7-8):904-14. doi: 10.1016/s0264-410x(98)00276-x. Vaccine. 1999. PMID: 10067697 Clinical Trial.

3

Vaccines for pandemic influenza.

Luke CJ, Subbarao K. Luke CJ, et al. Emerg Infect Dis. 2006 Jan;12(1):66-72. doi: 10.3201/eid1201.051147. Emerg Infect Dis. 2006. PMID: 16494720 Free PMC article. Review.

4

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.

Suguitan AL Jr, McAuliffe J, Mills KL, Jin H, Duke G, Lu B, Luke CJ, Murphy B, Swayne DE, Kemble G, Subbarao K. Suguitan AL Jr, et al. Among authors: luke cj. PLoS Med. 2006 Sep;3(9):e360. doi: 10.1371/journal.pmed.0030360. PLoS Med. 2006. PMID: 16968127 Free PMC article.

5

H5N1 viruses and vaccines.

Subbarao K, Luke C. Subbarao K, et al. PLoS Pathog. 2007 Mar;3(3):e40. doi: 10.1371/journal.ppat.0030040. PLoS Pathog. 2007. PMID: 17335350 Free PMC article. Review. No abstract available.

6

Toxicological evaluation of live attenuated, cold-adapted H5N1 vaccines in ferrets.

Jin H, Manetz S, Leininger J, Luke C, Subbarao K, Murphy B, Kemble G, Coelingh KL. Jin H, et al. Vaccine. 2007 Dec 17;25(52):8664-72. doi: 10.1016/j.vaccine.2007.10.032. Epub 2007 Nov 5. Vaccine. 2007. PMID: 18031873

7

FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007.

Eichelberger M, Golding H, Hess M, Weir J, Subbarao K, Luke CJ, Friede M, Wood D. Eichelberger M, et al. Among authors: luke cj. Vaccine. 2008 Aug 12;26(34):4299-303. doi: 10.1016/j.vaccine.2008.06.012. Epub 2008 Jun 26. Vaccine. 2008. PMID: 18582523

8

A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.

Karron RA, Callahan K, Luke C, Thumar B, McAuliffe J, Schappell E, Joseph T, Coelingh K, Jin H, Kemble G, Murphy BR, Subbarao K. Karron RA, et al. J Infect Dis. 2009 Mar 1;199(5):711-6. doi: 10.1086/596558. J Infect Dis. 2009. PMID: 19210163 Free PMC article. Clinical Trial.

9

Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.

Ambrose CS, Luke C, Coelingh K. Ambrose CS, et al. Influenza Other Respir Viruses. 2008 Nov;2(6):193-202. doi: 10.1111/j.1750-2659.2008.00056.x. Influenza Other Respir Viruses. 2008. PMID: 19453395 Free PMC article. Review.

10

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

Talaat KR, Karron RA, Callahan KA, Luke CJ, DiLorenzo SC, Chen GL, Lamirande EW, Jin H, Coelingh KL, Murphy BR, Kemble G, Subbarao K. Talaat KR, et al. Among authors: luke cj. Vaccine. 2009 Jun 8;27(28):3744-53. doi: 10.1016/j.vaccine.2009.03.082. Epub 2009 Apr 17. Vaccine. 2009. PMID: 19464558 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters